Mawi DNA Technologies

Mawi DNA Technologies has developed and commercialized iSWAB and HemaSure platforms for non-invasive biosample collection, enabling ambient temperature transport and storage of a wide range of biological samples. Their products are used globally in genomics, proteomics, microbiome studies, infectious disease surveillance (including COVID‑19), HIV monitoring programs in Africa, forensic analysis, animal health research, and more. The iSWAB-Microbiome EL product is notable for viral inactivation properties that allow labs to skip RNA extraction steps during COVID‑19 testing. The company received FDA 510(k) clearance for its iSWAB Respiratory Tract Sample Collection Media.